119 related articles for article (PubMed ID: 9566719)
21. High-level expression of the CD44 variant sharing exon v10 in renal cancer.
Kan M; Aki M; Akiyama K; Naruo S; Kanayama H; Kagawa S
Jpn J Cancer Res; 1995 Sep; 86(9):847-53. PubMed ID: 7591962
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer.
Yamamichi K; Uehara Y; Kitamura N; Nakane Y; Hioki K
Int J Cancer; 1998 Jun; 79(3):256-62. PubMed ID: 9645347
[TBL] [Abstract][Full Text] [Related]
23. CD44 expression in curettage and postoperative specimens of endometrial cancer.
Wojciechowski M; Krawczyk T; Śmigielski J; Malinowski A
Arch Gynecol Obstet; 2015 Feb; 291(2):383-90. PubMed ID: 25129125
[TBL] [Abstract][Full Text] [Related]
24. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
Givehchian M; Wörner S; Sträter J; Zöller M; Heuschen U; Heuschen G; Lehnert T; Herfarth C; von Knebel Doeberitz M
Eur J Cancer; 1998 Jun; 34(7):1099-1104. PubMed ID: 9849461
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.
Takazoe K; Foti R; Tesch GH; Hurst LA; Lan HY; Atkins RC; Nikolic-Paterson DJ
Clin Exp Immunol; 2000 Sep; 121(3):523-32. PubMed ID: 10971520
[TBL] [Abstract][Full Text] [Related]
26. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations.
Weber B; Rösel M; Arch R; Möller P; Zöller M
Differentiation; 1996 Mar; 60(1):17-29. PubMed ID: 8935925
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM
Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of CD44 variant 6 in human endometrial cancer and its prognostic significance.
Ayhan A; Tok EC; Bildirici I; Ayhan A
Gynecol Oncol; 2001 Mar; 80(3):355-8. PubMed ID: 11263931
[TBL] [Abstract][Full Text] [Related]
29. Expression of splice variants of CD44 in thyroid neoplasms derived from follicular cells.
Gu J; Daa T; Kashima K; Yokoyama S; Nakayama I; Noguchi S
Pathol Int; 1998 Mar; 48(3):184-90. PubMed ID: 9589486
[TBL] [Abstract][Full Text] [Related]
30. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
[TBL] [Abstract][Full Text] [Related]
31. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
Gotley DC; Fawcett J; Walsh MD; Reeder JA; Simmons DL; Antalis TM
Br J Cancer; 1996 Aug; 74(3):342-51. PubMed ID: 8695347
[TBL] [Abstract][Full Text] [Related]
32. Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans.
Imazeki F; Yokosuka O; Yamaguchi T; Ohto M; Isono K; Omata M
Gastroenterology; 1996 Feb; 110(2):362-8. PubMed ID: 8566581
[TBL] [Abstract][Full Text] [Related]
33. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.
Mulder JW; Kruyt PM; Sewnath M; Oosting J; Seldenrijk CA; Weidema WF; Offerhaus GJ; Pals ST
Lancet; 1994 Nov; 344(8935):1470-2. PubMed ID: 7526103
[TBL] [Abstract][Full Text] [Related]
34. Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma.
Gansauge F; Gansauge S; Rau B; Scheiblich A; Poch B; Schoenberg MH; Beger HG
Cancer; 1997 Nov; 80(9):1733-9. PubMed ID: 9351541
[TBL] [Abstract][Full Text] [Related]
35. Expression of CD44 isoforms in human skin cancer.
Simon JC; Heider KH; Dietrich A; Wuttig C; Schöpf E; Adolf GR; Ponta H; Herrlich P
Eur J Cancer; 1996 Jul; 32A(8):1394-400. PubMed ID: 8869105
[TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer.
Aaltomaa S; Lipponen P; Ala-Opas M; Kosma VM
Eur Urol; 2001 Feb; 39(2):138-44. PubMed ID: 11223672
[TBL] [Abstract][Full Text] [Related]
37. CD44 variant exon 6 expressions in colon cancer assessed by quantitative analysis using real time reverse transcriptase-polymerase chain reaction.
Yamada Y; Itano N; Narimatsu H; Kudo T; Hirohashi S; Ochiai A; Tohnai I; Ueda M; Kimata K
Oncol Rep; 2003; 10(6):1919-24. PubMed ID: 14534719
[TBL] [Abstract][Full Text] [Related]
38. CD44 variant exon epitopes in primary breast cancer and length of survival.
Kaufmann M; Heider KH; Sinn HP; von Minckwitz G; Ponta H; Herrlich P
Lancet; 1995 Mar; 345(8950):615-9. PubMed ID: 7534855
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
Weg-Remers S; Anders M; von Lampe B; Riecken EO; Schüder G; Feifel G; Zeitz M; Stallmach A
Eur J Cancer; 1998 Sep; 34(10):1607-11. PubMed ID: 9893637
[TBL] [Abstract][Full Text] [Related]
40. CD44 and the adhesion of neoplastic cells.
Rudzki Z; Jothy S
Mol Pathol; 1997 Apr; 50(2):57-71. PubMed ID: 9231152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
